Story · Medicine & Biotech

Mapping an enzyme offers clues to treating rare genetic disease

1 outlet · first reported by Medical Xpress on

Researchers at the Icahn School of Medicine at Mount Sinai have mapped an enzyme that could be targeted to develop new treatments for glutaric aciduria type 1 (GA1), a rare genetic disorder that can lead to brain damage, revealing new details about how the enzyme works and how its activity is… (Medical Xpress)

Coverage, in order

  1. Mapping an enzyme offers clues to treating rare genetic disease

    Researchers at the Icahn School of Medicine at Mount Sinai have mapped an enzyme that could be targeted to develop new treatments for glutaric aciduria type 1 (GA1), a rare genetic disorder that can lead to brain damage, revealing new details about how the enzyme works and how its activity is…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.